Document

We consent to the incorporation by reference in Registration Statement No.’s 333-238922, 333-254361, 333-263127 and 333-270428 on Form S-8, and Registration Statement No. 333-270862 on Form S-3 of our reports dated February 27, 2024, relating to the financial statements of Pliant Therapeutics, Inc. and the effectiveness of Pliant Therapeutics, Inc.’s internal control over financial reporting appearing in the Annual Report on Form 10-K of Pliant Therapeutics, Inc. for the year ended December 31, 2023.